CNS Metastases in HER2-Positive Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan: DESTINY-Breast01 Subgroup Analyses. European Society for Medical Oncology (ESMO) Breast Cancer Virtual Meeting, May 2020. #1380 - Jerusalem, G; Park, Y H; Yamashita, T